COVID-19-associated acute disseminated encephalomyelitis (ADEM)

191Citations
Citations of this article
336Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 51-year-old woman with COVID-19 infection developed coma and an impaired oculocephalic response to one side. MRI of the brain demonstrated acute multifocal demyelinating lesions, and CSF testing did not identify a direct cerebral infection. High-dose steroids followed by a course of IVIG was administered, and the patient regained consciousness over the course of several weeks. As more patients reach the weeks after initial infection with COVID-19, acute disseminated encephalomyelitis should be considered a potentially treatable cause of profound encephalopathy or multifocal neurological deficits.

Cite

CITATION STYLE

APA

Parsons, T., Banks, S., Bae, C., Gelber, J., Alahmadi, H., & Tichauer, M. (2020, October 1). COVID-19-associated acute disseminated encephalomyelitis (ADEM). Journal of Neurology. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00415-020-09951-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free